FDA Approves In-home Breast Cancer Treatment
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
U.S. Food and Drug Administration approved Phesgo—a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf—for injection under the skin to treat adult patients with HER2-positive breast cancer that has spread to other parts of the body, and for treatment of adult patients with early HER2-positive breast cancer.

• HER2-positive breast cancer has too much of a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells.

• Pertuzumab and trastuzumab bind to sites on HER2 and disrupt signaling to stop cancer cell growth.

• Phesgo contains a fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase for injection under the skin.

• Phesgo is initially used in combination with chemotherapy and could continue to be administered at home by a qualified health care professional once the chemotherapy regimen is finished.

• The most common side effects for patients taking Phesgo were alopecia (hair loss), nausea, diarrhea, anemia (reduced number of red blood cells) and asthenia (lack of energy).

• The FDA granted approval of Phesgo to Genentech Inc.

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-breast-cancer-treatment-can-be-administered-home-health-care-professional
Dr. T●●●●z H●●●●●●i and 2 other likes this
Like
Comment
Share